Takeda announces positive data from three phase 3...
Category : Clinical Trial Update 1 October 2026Takeda announced new data from three phase 3 LATITUDE psoriasis studies of zasocitinib (TAK-279), an...
Clinical Trial Update
Tolerance Bio Licenses TLB-33 From Tanabe Pharma f...
Category : Clinical Trial Update 30 September 2026Agreement Gives Tolerance Bio Worldwide Development Rights Outside Japan Tolerance Bio, Inc. has...
Airway Therapeutics Receives $1.9 Million NIH Gran...
Category : Clinical Trial Update 30 September 2026Funding Will Support U.S. Clinical Development in Extremely Preterm Infants Airway Therapeutics,...
Vanda Reports Positive Phase III Results for HETLI...
Category : Clinical Trial Update 30 September 2026Phase III Study Meets Primary Endpoint in Adults With DSWPD Vanda Pharmaceuticals Inc. has report...
Johnson & Johnson Reports Positive Phase 4 STAR Re...
Category : Clinical Trial Update 29 September 2026Tremfya Meets Main Study Goals in Patients With Axial Involvement Johnson & Johnson has annou...
Latest Newsletter Post
-
Takeda announces positive data from..
1 October 2026
-
Vanda Reports Positive Phase III Re..
30 September 2026
-
Airway Therapeutics Receives $1.9 M..
30 September 2026
-
Tolerance Bio Licenses TLB-33 From..
30 September 2026
-
Ascletis Reports Positive Phase I R..
29 September 2026
